346 related articles for article (PubMed ID: 25934595)
1. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ
J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595
[TBL] [Abstract][Full Text] [Related]
2. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.
Eschenhagen T; Mummery C; Knollmann BC
Cardiovasc Res; 2015 Apr; 105(4):424-38. PubMed ID: 25618410
[TBL] [Abstract][Full Text] [Related]
3. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.
Ross SB; Fraser ST; Semsarian C
Trends Cardiovasc Med; 2016 Nov; 26(8):663-672. PubMed ID: 27296521
[TBL] [Abstract][Full Text] [Related]
5. Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models.
Buikema JW; Wu SM
Curr Cardiol Rep; 2017 Apr; 19(4):30. PubMed ID: 28315121
[TBL] [Abstract][Full Text] [Related]
6. Human-induced pluripotent stem cell models of inherited cardiomyopathies.
Karakikes I; Termglinchan V; Wu JC
Curr Opin Cardiol; 2014 May; 29(3):214-9. PubMed ID: 24576884
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Tissue Engineering Models of Inherited and Acquired Cardiomyopathies.
Turnbull IC; Mayourian J; Murphy JF; Stillitano F; Ceholski DK; Costa KD
Methods Mol Biol; 2018; 1816():145-159. PubMed ID: 29987817
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
[TBL] [Abstract][Full Text] [Related]
9. Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.
Brodehl A; Ebbinghaus H; Deutsch MA; Gummert J; Gärtner A; Ratnavadivel S; Milting H
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31489928
[TBL] [Abstract][Full Text] [Related]
10. From Hypertrophy to Heart Failure: What Is New in Genetic Cardiomyopathies.
Reza N; Musunuru K; Owens AT
Curr Heart Fail Rep; 2019 Oct; 16(5):157-167. PubMed ID: 31243690
[TBL] [Abstract][Full Text] [Related]
11. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
Ramachandra CJA; Chua J; Cong S; Kp MMJ; Shim W; Wu JC; Hausenloy DJ
Cardiovasc Res; 2021 Feb; 117(3):694-711. PubMed ID: 32365198
[TBL] [Abstract][Full Text] [Related]
12. Human Cardiac Organoids for Modeling Genetic Cardiomyopathy.
Filippo Buono M; von Boehmer L; Strang J; Hoerstrup SP; Emmert MY; Nugraha B
Cells; 2020 Jul; 9(7):. PubMed ID: 32698471
[TBL] [Abstract][Full Text] [Related]
13. Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy.
Prajapati C; Ojala M; Aalto-Setälä K
Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29361520
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells for the study of cardiovascular disease.
Savla JJ; Nelson BC; Perry CN; Adler ED
J Am Coll Cardiol; 2014 Aug; 64(5):512-9. PubMed ID: 25082586
[TBL] [Abstract][Full Text] [Related]
15. Human Induced Pluripotent Stem Cells for Inherited Cardiovascular Diseases Modeling.
Jiang W; Lan F; Zhang H
Curr Stem Cell Res Ther; 2016; 11(7):533-41. PubMed ID: 25322695
[TBL] [Abstract][Full Text] [Related]
16. Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy.
Cho GS; Lee DI; Tampakakis E; Murphy S; Andersen P; Uosaki H; Chelko S; Chakir K; Hong I; Seo K; Chen HV; Chen X; Basso C; Houser SR; Tomaselli GF; O'Rourke B; Judge DP; Kass DA; Kwon C
Cell Rep; 2017 Jan; 18(2):571-582. PubMed ID: 28076798
[TBL] [Abstract][Full Text] [Related]
17. Disease Modeling and Disease Gene Discovery in Cardiomyopathies: A Molecular Study of Induced Pluripotent Stem Cell Generated Cardiomyocytes.
Kumar S; Curran JE; Kumar K; DeLeon E; Leandro AC; Peralta J; Williams-Blangero S; Blangero J
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805011
[TBL] [Abstract][Full Text] [Related]
18. Modeling of human cardiomyopathy with induced pluripotent stem cells.
Lee YK; Ng KM; Tse HF
J Biomed Nanotechnol; 2014 Oct; 10(10):2562-85. PubMed ID: 25992409
[TBL] [Abstract][Full Text] [Related]
19. Modeling Cardiomyopathies in a Dish: State-of-the-Art and Novel Perspectives on hiPSC-Derived Cardiomyocytes Maturation.
Lodola F; De Giusti VC; Maniezzi C; Martone D; Stadiotti I; Sommariva E; Maione AS
Biology (Basel); 2021 Jul; 10(8):. PubMed ID: 34439963
[TBL] [Abstract][Full Text] [Related]
20. hiPSC Modeling of Inherited Cardiomyopathies.
Jung G; Bernstein D
Curr Treat Options Cardiovasc Med; 2014 Jul; 16(7):320. PubMed ID: 24838688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
